Stroke

被引：13

作者：

Kothari, RU

Hacke, W

Brott, T

Dykstra, EH

Furlan, A

Koroshetz, W

Marler, J

Sayre, MR

机构：

[1] Borges Hosp, Borges Res Inst, Kalamazoo, MI 49001 USA

[2] Heidelberg Univ, Heidelberg, Germany

[3] Mayo Clin Jacksonville, Jacksonville, FL 32224 USA

[4] PECEMMS Fdn, Apeldoom, Netherlands

[5] Cleveland Clin Fdn, Cleveland, OH 44195 USA

[6] Massachusetts Gen Hosp, Boston, MA 02114 USA

[7] NIH, Bethesda, MD 20892 USA

[8] Univ Cincinnati, Cincinnati, OH USA

来源：

ANNALS OF EMERGENCY MEDICINE | 2001年 / 37卷 / 04期

关键词：

D O I：

10.1067/mem.2001.114171

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

[No abstract available]

引用

页码：S137 / S144

页数：8

共 27 条

[1] Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke - A statement for healthcare professionals from a special writing group of the stroke council, American Heart Association [J].

Adams, HP ;

Brott, TG ;

Furlan, AJ ;

Gomez, CR ;

Grotta, J ;

Helgason, CM ;

Kwiatkowski, T ;

Lyden, PD ;

Marler, JR ;

Torner, J ;

Feinberg, W ;

Mayberg, M ;

Thies, W .

CIRCULATION, 1996, 94 (05) :1167-1174

[2]

[Anonymous], STROKE

[3] Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI [J].

Barber, PA ;

Darby, DG ;

Desmond, PM ;

Yang, Q ;

Gerraty, RP ;

Jolley, D ;

Donnan, GA ;

Tress, BM ;

Davis, SM .

NEUROLOGY, 1998, 51 (02) :418-426

[4] TIME OF HOSPITAL PRESENTATION IN PATIENTS WITH ACUTE STROKE [J].

BARSAN, WG ;

BROTT, TG ;

BRODERICK, JP ;

HALEY, EC ;

LEVY, DE ;

MARLER, JR .

ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (22) :2558-2561

[5] A systems approach to immediate evaluation and management of hyperacute stroke - Experience at eight centers and implications for community practice and patient care [J].

Brott, T ;

Broderick, J ;

Kothari, R ;

ODonoghue, M ;

Barsan, W ;

Tomsick, T ;

Spilker, J ;

Miller, R ;

Sauerbeck, L ;

Farrell, J ;

Kelly, J ;

Perkins, T ;

McDonald, T ;

Rorick, M ;

Hickey, C ;

Armitage, J ;

Perry, C ;

Thalinger, K ;

Rhude, R ;

Schill, J ;

Becker, PS ;

Heath, RS ;

Adams, D ;

Reed, R ;

Klei, M ;

Hughes, A ;

Anthony, J ;

Baudendistel, D ;

Zadicoff, C ;

Rymer, M ;

Bettinger, I ;

Laubinger, P ;

Schmerler, M ;

Meiros, G ;

Lyden, P ;

Dunford, J ;

Zivin, J ;

Rapp, K ;

Babcock, T ;

Daum, P ;

Persona, D ;

Brody, M ;

Jackson, C ;

Lewis, S ;

Liss, J ;

Mahdavi, Z ;

Rothrock, J ;

Tom, T ;

Zweifler, R ;

Kobayashi, J .

STROKE, 1997, 28 (08) :1530-1540

[6]

CANDELISE L, 1995, LANCET, V346, P1509

[7] Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset - The ATLANTIS study: A randomized controlled trial [J].

Clark, WM ;

Wissman, S ;

Albers, GW ;

Jhamandas, JH ;

Madden, KP ;

Hamilton, S .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2019-2026

[8]

CUMMINS R, 1997, ADV CARDIAC LIFE SUP

[9] PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke [J].

del Zoppo, GJ ;

Higashida, RT ;

Furlan, AJ ;

Pessin, MS ;

Rowley, HA ;

Gent, M .

STROKE, 1998, 29 (01) :4-11

[10] Streptokinase for acute ischemic stroke with relationship to time of administration [J].

Donnan, GA ;

Davis, SM ;

Chambers, BR ;

Gates, PC ;

Hankey, GJ ;

McNeil, JJ ;

Rosen, D ;

StewartWynne, EG ;

Tuck, RR .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (12) :961-966

← 1 2 3 →